Oral GLP-1 tracker: Wegovy pill holds about 75% of US pill scripts versus Foundayo
Using IQVIA data via Citi and Jefferies, Fierce Pharma says weekly US prescriptions dipped over a holiday week to about 173,000 for the Wegovy pill and 58,000 for Foundayo. Novo holds nearly three-quarters of the oral GLP-1 market so far, a useful signal for how the two pills may compete in the UK.
Source: Fierce Pharma (23 Oct 2026).